Literature DB >> 24855006

Intestinal microbiome and lymphoma development.

Mitsuko L Yamamoto1, Robert H Schiestl.   

Abstract

The intestinal microbiota and gut immune system must communicate to maintain a balance between tolerance and activation. Our immune system protects us from pathogenic microbes at the same time that our bodies are host to trillions of microbes, symbionts, mutualists, and some that are essential to human health. Since there is such a close interaction between the immune system and the intestinal microbiota, it is not surprising that some lymphomas such as mucosal-associated lymphoid tissue lymphoma have been shown to be caused by the presence of certain bacteria. Animal models have played an important role in elucidating the causation and establishing the mechanism of bacteria-induced mucosal-associated lymphoid tissue lymphoma. In this review, we discuss different ways that animal models have been applied to investigate links between the gut microbiota and lymphoma and have helped to reveal the mechanisms of microbiota-induced lymphoma. Although there is a paucity of published studies demonstrating the interplay between the microbiota and lymphoma development, we believe that the connection is real and that it can be exploited in the future to enhance our understanding of causation and to improve the prognosis and treatment of lymphoma.

Entities:  

Mesh:

Year:  2014        PMID: 24855006      PMCID: PMC4047521          DOI: 10.1097/PPO.0000000000000047

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  95 in total

Review 1.  Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation.

Authors:  Felipe Suarez; Olivier Lortholary; Olivier Hermine; Marc Lecuit
Journal:  Blood       Date:  2006-01-05       Impact factor: 22.113

2.  Commensal microbiota alter the abundance and TCR responsiveness of splenic naïve CD4+ T lymphocytes.

Authors:  Tiffany Huang; Bo Wei; Peter Velazquez; James Borneman; Jonathan Braun
Journal:  Clin Immunol       Date:  2005-11-14       Impact factor: 3.969

Review 3.  Bacterial regulation of intestinal immune responses.

Authors:  Thomas T MacDonald; John N Gordon
Journal:  Gastroenterol Clin North Am       Date:  2005-09       Impact factor: 3.806

4.  An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system.

Authors:  Sarkis K Mazmanian; Cui Hua Liu; Arthur O Tzianabos; Dennis L Kasper
Journal:  Cell       Date:  2005-07-15       Impact factor: 41.582

5.  IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells.

Authors:  A M Oliver; F Martin; J F Kearney
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

6.  DNA damage and repair in Helicobacter pylori-infected gastric mucosa cells.

Authors:  Michal Arabski; Grazyna Klupinska; Jan Chojnacki; Pawel Kazmierczak; Maria Wisniewska-Jarosinska; Jozef Drzewoski; Janusz Blasiak
Journal:  Mutat Res       Date:  2005-02-15       Impact factor: 2.433

7.  Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors.

Authors:  Hideki Ishikawa; Ikuko Akedo; Toru Otani; Takaichiro Suzuki; Tomiyo Nakamura; Ikuko Takeyama; Shingo Ishiguro; Etsuo Miyaoka; Tomotaka Sobue; Tadao Kakizoe
Journal:  Int J Cancer       Date:  2005-09-20       Impact factor: 7.396

8.  The gut microbiota as an environmental factor that regulates fat storage.

Authors:  Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

Review 9.  Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms.

Authors:  Tahseen Al-Saleem; Hamid Al-Mondhiry
Journal:  Blood       Date:  2004-11-12       Impact factor: 22.113

10.  Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity.

Authors:  Richard J Bende; Wilhelmina M Aarts; Robert G Riedl; Daphne de Jong; Steven T Pals; Carel J M van Noesel
Journal:  J Exp Med       Date:  2005-04-18       Impact factor: 14.307

View more
  13 in total

Review 1.  When human cells meet bacteria: precision medicine for cancers using the microbiota.

Authors:  Han Zhang; Litao Sun
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

Review 2.  Heavy Chain Disease of the Small Bowel.

Authors:  Giada Bianchi; Aliyah R Sohani
Journal:  Curr Gastroenterol Rep       Date:  2018-01-25

3.  Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitro.

Authors:  Fu-Cai Wang; Jing-Xuan Pei; Jun Zhu; Nan-Jin Zhou; Dong-Sheng Liu; Hui-Fang Xiong; Xiao-Qun Liu; Dong-Jia Lin; Yong Xie
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

Review 4.  The interplay between the intestinal microbiota and the immune system.

Authors:  Yuk Man Kevin Lei; Lekha Nair; Maria-Luisa Alegre
Journal:  Clin Res Hepatol Gastroenterol       Date:  2014-11-11       Impact factor: 2.947

Review 5.  Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.

Authors:  Antonio Galvao Neto; April Whitaker; Zhiheng Pei
Journal:  Semin Oncol       Date:  2015-09-07       Impact factor: 4.929

Review 6.  Understanding Luminal Microorganisms and Their Potential Effectiveness in Treating Intestinal Inflammation.

Authors:  M Nedim Ince; Bruce R Blazar; Michael B Edmond; Guido Tricot; Michael J Wannemuehler
Journal:  Inflamm Bowel Dis       Date:  2016-01       Impact factor: 5.325

7.  Male Syrian Hamsters Experimentally Infected with Helicobacter spp. of the H. bilis Cluster Develop MALT-Associated Gastrointestinal Lymphomas.

Authors:  Stephanie E Woods; Courtney Ek; Zeli Shen; Yan Feng; Zhongming Ge; Sureshkumar Muthupalani; Mark T Whary; James G Fox
Journal:  Helicobacter       Date:  2015-09-08       Impact factor: 5.753

8.  A Preclinical Model for the ATLL Lymphoma Subtype With Insights Into the Role of Microenvironment in HTLV-1-Mediated Lymphomagenesis.

Authors:  Mattia Vicario; Adriana Mattiolo; Barbara Montini; Maria Assunta Piano; Ilaria Cavallari; Alberto Amadori; Luigi Chieco-Bianchi; Maria Luisa Calabrò
Journal:  Front Microbiol       Date:  2018-06-13       Impact factor: 5.640

Review 9.  Potential Application of Combined Therapy with Lectins as a Therapeutic Strategy for the Treatment of Bacterial Infections.

Authors:  João Victor de Oliveira Santos; Ana Lúcia Figueiredo Porto; Isabella Macário Ferro Cavalcanti
Journal:  Antibiotics (Basel)       Date:  2021-05-02

10.  Relationship of the mucosal microbiota to gastrointestinal inflammation and small cell intestinal lymphoma in cats.

Authors:  Kayode Garraway; Chad M Johannes; Angela Bryan; John Peauroi; Giacomo Rossi; Min Zhang; Chong Wang; Karin Allenspach; Albert E Jergens
Journal:  J Vet Intern Med       Date:  2018-08-07       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.